Altuzan 400 mg (Bevacizumab 400 mg / 16 ml) by Roche.
Indications: Metastatic colorectal cancer, breast cancer, NSCLC, renal cell carcinoma, ovarian and cervical cancer, per SmPC.
Administration: Intravenous infusion every 2 or 3 weeks per protocol.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Roche |
| Active ingredient | Bevacizumab 400 mg / 16 ml (25 mg/ml) — anti-VEGF monoclonal antibody (Avastin equivalent brand name used in some markets). |
| Strength & pack | 1 vial of 16 ml. |
| Form | Concentrate for solution for infusion |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |